When Type 1 Diabetes Isn't Type 1: How GCK-MODY Gets Misdiagnosed

Type 1 diabetes is not always what it seems. A new study from pediatric endocrinologists in Turkey looked at 20 children who initially appeared to have Type 1 diabetes but actually had a completely different condition: glucokinase maturity-onset diabetes of the young (GCK-MODY).

GCK-MODY is a rare genetic form of diabetes caused by mutations in a single gene that affects how the body regulates blood sugar. Unlike Type 1 diabetes, which results from the immune system attacking insulin-producing cells, GCK-MODY develops from an inherited genetic change that disrupts the body's glucose sensor.

The troubling finding: 35% of the children in this study—seven out of 20—had been diagnosed and treated as Type 1 diabetes patients before anyone recognized they actually had GCK-MODY. Most of these children had been given insulin therapy despite not needing it.

So how can GCK-MODY hide behind a Type 1 diabetes diagnosis? The answer lies in what doctors find—and don't find—when they test.

In this study, all of the children with genetically confirmed GCK-MODY tested negative for diabetes-related autoantibodies. This is a crucial distinction: Type 1 diabetes develops when the immune system produces antibodies against insulin-producing cells. If those antibodies are absent, Type 1 diabetes should be questioned.

The children's average HbA1c level was 6.2%, which is relatively well-controlled. Their most common presenting symptoms were increased thirst and urination (in 30% of cases) or high blood sugar found incidentally during routine exams (in 25% of cases).

Perhaps the most striking finding was the timing. The median time between a child's initial medical evaluation and their eventual genetic diagnosis of GCK-MODY was 3.5 years—and for some children, the delay stretched as long as 8.4 years.

This delay matters. While children were waiting for the correct diagnosis, they were being treated with insulin, which may not have been necessary for their condition. A correct diagnosis earlier could have changed their treatment plan and reduced unnecessary medical interventions.

The genetic changes behind GCK-MODY are specific: researchers found missense variants in 95% of patients and one frameshift variant in 5%. The most common variant appeared in nearly half the study population, suggesting it may be worth screening for in certain families.

GCK-MODY is rare, but it is real—and it is being missed. The researchers point to a broader problem: limited awareness among doctors about this condition and a lack of screening among family members of affected children.

If you or a family member has been diagnosed with Type 1 diabetes but tests negative for autoantibodies, this study underscores the importance of asking whether genetic testing for MODY variants has been considered. A simple genetic test can confirm or rule out this diagnosis and guide the right treatment approach.

Awareness and earlier recognition could spare families years of uncertainty and inappropriate treatment. The more clinicians and families know about the signs of GCK-MODY, the sooner the correct diagnosis can be made.

Source: Turkish archives of pediatrics. Evidence type: PubMed indexed literature. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.